Synthetic biology approaches to engineer T cells
Year: 2015
Type: review
Source: Current Opinion in Immunology
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Exploring Design Principles of Cellular Control Circuits, Protein Recognition in Signal Transduction, Redesigning the T cell: Using Synthetic Biology to Engineer Therapeutic Cells, Cellular Control: Synthetic Signaling/Motility (RMI), Harnessing CRISPR for Targeted and Inducible Epigenomic Reprogramming
OpenAlex ID: W999972457
